IVBXF   $4.67  -7.34% Market Open

Innovent Biologics Inc
Total Cash 8.63B
totalCashPerShare 5.299
EBITDA -990.62M
Total Debt 3.35B
quickRatio 2.422
currentRatio 2.677
Total Revenue 7.46B
debtToEquity 26.949
Revenue/Share 4.651
ROA -0.041810002
ROE -0.110419996
grossProfits
freeCashflow -176.40M
operatingCashflow 555.07M
earningsGrowth
revenueGrowth 0.463
grossMargins 0.71577
ebitdaMargins -0.13284999
operatingMargins -0.10938
profitMargins -0.17184
enterpriseValue 2.00B
forwardPE
floatShares 1.42B
sharesOutstanding 1.63B
sharesShort
sharesShortPriorMonth
dateShortInterest
sharesPercentSharesOut
heldPercentInsiders 0.07%
heldPercentInstitutions 0.48%
Short Ratio help_outline
shortPercentOfFloat
impliedSharesOutstanding
bookValue 7.631
Price To Book help_outline 0.59
earningsQuarterlyGrowth
netIncomeToCommon -1.28B
trailingEps -0.11%
forwardEps
enterpriseToEbitda -2.02
lastDividendValue
lastDividendDate
currentQuarterEstimate
institutionsCount 322
lastUpdated Nov. 7, 2024, 1:19 p.m.